Aytu BioScience Inc is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The company markets ProstaScint (capromab pendetide), a radio-imaging agent indicated to detect the prostate-specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. Other products of the company include MiOXSYS, a novel in vitro diagnostic device, Natesto (testosterone) nasal gel, and Fiera Personal Care Device. The company, through its wholly-owned subsidiary Nuelle, Inc, is also focused on women’s sexual wellbeing and intimacy.